Select Medical Holdings Corporation (SEM) 10-Year Financial Performance & Capital Metrics

SEM • • Industrial / General

HealthcareHealthcare FacilitiesRehabilitation & Therapy ServicesInpatient Rehabilitation Hospitals

AboutSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.Show more

Revenue $5.19B -22.2%
EBITDA $472M -38.2%
Net Income $214M -12.1%
EPS (Diluted) 1.66 -13.1%
Gross Margin 12.22% -12.7%
EBITDA Margin 9.1% -20.6%
Operating Margin 5.17% -37.9%
Net Margin 4.13% +12.9%
ROE 11.99% -27.0%
ROIC 3.77% -43.5%
Debt/Equity 1.35 -52.9%
Interest Coverage 2.09 -25.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 3.4%
✓Trading at only 1.0x book value

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y5.4%

5Y-1%

3Y-5.8%

TTM-34.98%

Profit (Net Income) CAGR

10Y5.9%

5Y7.59%

3Y-18.96%

TTM-60.2%

EPS CAGR

10Y6.2%

5Y1.51%

3Y-17.81%

TTM-59.35%

ROCE

10Y Avg8.13%

5Y Avg8.08%

3Y Avg6.61%

Latest4.85%

Peer Comparison

Inpatient Rehabilitation Hospitals

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
EHCEncompass Health Corporation	10.34B	102.80	23.05	11.91%	9.33%	16.98%	3.48%	0.95
SEMSelect Medical Holdings Corporation	1.91B	15.42	9.29	-22.16%	2.8%	5.47%	28.26%	1.35

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	3.74B	4.29B	4.44B	5.08B	5.45B	5.53B	6.2B	6.33B	6.66B	5.19B
Revenue Growth %	0.22%	0.15%	0.04%	0.14%	0.07%	0.01%	0.12%	0.02%	0.05%	-0.22%
Cost of Goods Sold+	3.21B	3.66B	3.73B	4.34B	4.64B	4.71B	5.29B	5.6B	5.73B	4.55B
COGS % of Revenue	0.86%	0.86%	0.84%	0.85%	0.85%	0.85%	0.85%	0.88%	0.86%	0.88%
Gross Profit+	531.2M	621.18M	709.43M	740.2M	812.92M	821.34M	919.37M	733.38M	932.04M	633.64M
Gross Margin %	0.14%	0.14%	0.16%	0.15%	0.15%	0.15%	0.15%	0.12%	0.14%	0.12%
Gross Profit Growth %	0.1%	0.17%	0.14%	0.04%	0.1%	0.01%	0.12%	-0.2%	0.27%	-0.32%
Operating Expenses+	197.03M	252.24M	274.06M	322.92M	341.04M	253.68M	205.59M	330.09M	377.17M	365.33M
OpEx % of Revenue	0.05%	0.06%	0.06%	0.06%	0.06%	0.05%	0.03%	0.05%	0.06%	0.07%
Selling, General & Admin	92.05M	106.93M	114.05M	121.27M	128.46M	138.04M	146.97M	153.03M	170.19M	225.87M
SG&A % of Revenue	0.02%	0.02%	0.03%	0.02%	0.02%	0.02%	0.02%	0.02%	0.03%	0.04%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	104.98M	42.65M	-49K	201.66M	212.58M	115.65M	58.62M	177.06M	206.97M	139.46M
Operating Income+	274.79M	299.85M	355.88M	417.28M	471.88M	567.66M	713.77M	403.28M	554.87M	268.31M
Operating Margin %	0.07%	0.07%	0.08%	0.08%	0.09%	0.1%	0.12%	0.06%	0.08%	0.05%
Operating Income Growth %	-0.03%	0.09%	0.19%	0.17%	0.13%	0.2%	0.26%	-0.43%	0.38%	-0.52%
EBITDA+	379.77M	445.16M	515.89M	618.93M	684.46M	773.32M	916.42M	609.11M	763.62M	472.21M
EBITDA Margin %	0.1%	0.1%	0.12%	0.12%	0.13%	0.14%	0.15%	0.1%	0.11%	0.09%
EBITDA Growth %	0.08%	0.17%	0.16%	0.2%	0.11%	0.13%	0.19%	-0.34%	0.25%	-0.38%
D&A (Non-Cash Add-back)	104.98M	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M
EBIT	279.5M	303.08M	357.16M	420.17M	465.32M	477.64M	765.71M	429.69M	581M	303.37M
Net Interest Income+	-112.82M	-170.08M	-154.7M	-198.49M	-200.57M	-153.01M	-130.63M	-169.11M	-198.64M	-128.6M
Interest Income	0	0	0	0	0	0	5.35M	0	0	0
Interest Expense	112.82M	170.08M	154.7M	198.49M	200.57M	153.01M	135.99M	169.11M	198.64M	128.6M
Other Income/Expense	-66.36M	-119.11M	-153.42M	-181.73M	-207.13M	-111.18M	-84.05M	-142.7M	-172.52M	-93.55M
Pretax Income+	208.43M	180.73M	202.46M	235.55M	264.75M	456.47M	629.72M	260.58M	382.36M	174.77M
Pretax Margin %	0.06%	0.04%	0.05%	0.05%	0.05%	0.08%	0.1%	0.04%	0.06%	0.03%
Income Tax+	72.44M	55.46M	-18.18M	58.61M	63.72M	111.87M	129.77M	62.55M	82.63M	44.78M
Effective Tax Rate %	0.63%	0.64%	0.88%	0.59%	0.56%	0.57%	0.64%	0.61%	0.64%	1.22%
Net Income+	130.74M	115.41M	177.18M	137.84M	148.45M	259M	402.23M	158.99M	243.49M	214.04M
Net Margin %	0.03%	0.03%	0.04%	0.03%	0.03%	0.05%	0.06%	0.03%	0.04%	0.04%
Net Income Growth %	0.08%	-0.12%	0.54%	-0.22%	0.08%	0.74%	0.55%	-0.6%	0.53%	-0.12%
Net Income (Continuing)	136M	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	129.99M
Discontinued Operations	0	0	0	0	0	0	0	0	0	166.72M
Minority Interest	49.26M	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M
EPS (Diluted)+	0.99	0.87	0.87	1.06	1.54	1.93	2.99	1.23	1.91	1.66
EPS Growth %	0.09%	-0.12%	0%	0.22%	0.45%	0.25%	0.55%	-0.59%	0.55%	-0.13%
EPS (Basic)	1.00	0.88	1.33	1.06	1.54	1.93	2.99	1.23	1.91	1.66
Diluted Shares Outstanding	127.75M	127.97M	129.13M	130.26M	130.28M	129.78M	130.25M	124.63M	123.11M	124.61M
Basic Shares Outstanding	127.48M	127.81M	128.96M	130.17M	130.25M	129.78M	130.25M	124.63M	123.11M	129.19M
Dividend Payout Ratio	0.1%	-	-	-	-	-	0.13%	0.41%	0.26%	0.3%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	749.15M	808.07M	920.83M	992.52M	1.21B	1.59B	1.14B	1.27B	1.26B	1.02B
Cash & Short-Term Investments	14.44M	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	172.76M	111.59M	59.69M
Cash Only	14.44M	99.03M	122.55M	175.18M	335.88M	577.06M	74.31M	97.91M	52.63M	59.69M
Short-Term Investments	0	0	0	0	0	0	0	74.86M	58.96M	0
Accounts Receivable	603.56M	573.75M	691.73M	706.68M	768.38M	896.76M	889.3M	941.31M	724.14M	821.38M
Days Sales Outstanding	58.86	48.86	56.82	50.76	51.42	59.17	52.32	54.25	39.66	57.8
Inventory	-589.3M	-627.62M	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	114.47M	90.12M	106.55M	110.67M	90.15M	114.49M	120.21M	125.37M	407.16M	138.7M
Total Non-Current Assets+	3.68B	4.14B	4.21B	4.97B	6.13B	6.06B	6.22B	6.39B	6.43B	4.59B
Property, Plant & Equipment	864.12M	892.22M	912.59M	979.81M	2B	1.98B	2.04B	2.17B	1.64B	1.78B
Fixed Asset Turnover	4.33x	4.80x	4.87x	5.19x	2.72x	2.80x	3.04x	2.92x	4.07x	2.91x
Goodwill	2.31B	2.75B	2.78B	3.32B	3.39B	3.38B	3.45B	3.48B	2.28B	2.33B
Intangible Assets	318.68M	340.56M	326.52M	437.69M	409.07M	387.54M	374.88M	351.66M	105.15M	103.18M
Long-Term Investments	-3.53B	-4.03B	114.2M	146.9M	28.7M	2.5M	18.05M	45.2M	0	320.9M
Other Non-Current Assets	3.68B	4.14B	184.42M	233.51M	295.18M	316.71M	338.67M	341.74M	2.41B	51.91M
Total Assets+	4.43B	4.94B	5.13B	5.96B	7.34B	7.66B	7.36B	7.67B	7.69B	5.61B
Asset Turnover	0.85x	0.87x	0.87x	0.85x	0.74x	0.72x	0.84x	0.83x	0.87x	0.92x
Asset Growth %	0.51%	0.12%	0.04%	0.16%	0.23%	0.04%	-0.04%	0.04%	0%	-0.27%
Total Current Liabilities+	737.69M	571.63M	605.4M	705.19M	914.28M	1.44B	1.27B	1.16B	1.25B	977.65M
Accounts Payable	137.41M	126.56M	128.19M	146.69M	145.73M	177.09M	233.84M	186.73M	153.9M	142.16M
Days Payables Outstanding	15.62	12.6	12.53	12.33	11.46	13.72	16.15	12.17	9.8	11.4
Short-Term Debt	253.78M	53.02M	51.65M	68.95M	233.12M	233.03M	59.92M	76.31M	99.15M	46.07M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	0	0	1000K	0	0	0
Other Current Liabilities	217.11M	0	255.93M	313.49M	224.93M	662.6M	0	0	271.28M	0
Current Ratio	1.02x	1.41x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x
Quick Ratio	1.81x	2.51x	1.52x	1.41x	1.33x	1.11x	0.90x	1.10x	1.01x	1.04x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	2.78B	3.47B	3.59B	4.34B	4.52B	4.57B	4.72B	5.12B	4.87B	2.63B
Long-Term Debt	2.16B	2.69B	2.68B	3.25B	3.42B	3.39B	3.56B	3.84B	3.58B	1.69B
Capital Lease Obligations	0	0	0	0	852.9M	875.37M	916.54M	1.01B	668.56M	797.14M
Deferred Tax Liabilities	218.71M	222.85M	124.92M	153.9M	148.26M	132.42M	142.79M	169.79M	119.94M	81.5M
Other Non-Current Liabilities	371.44M	558.68M	145.71M	158.94M	101.33M	168.7M	106.44M	106.14M	494.27M	73.04M
Total Liabilities	3.52B	4.04B	4.19B	5.05B	5.44B	6B	6B	6.27B	6.12B	3.61B
Total Debt+	2.45B	2.74B	2.7B	3.29B	4.51B	4.5B	4.76B	5.16B	4.52B	2.7B
Net Debt	2.44B	2.64B	2.58B	3.12B	4.17B	3.92B	4.69B	5.06B	4.47B	2.64B
Debt / Equity	2.56x	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x
Debt / EBITDA	6.46x	6.15x	5.23x	5.32x	6.58x	5.82x	5.20x	8.47x	5.93x	5.73x
Net Debt / EBITDA	6.42x	5.93x	5.00x	5.04x	6.09x	5.07x	5.12x	8.31x	5.86x	5.60x
Interest Coverage	2.44x	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x
Total Equity+	957.78M	996.08M	1.04B	1.03B	1.9B	1.65B	1.36B	1.39B	1.57B	2B
Equity Growth %	0.18%	0.04%	0.05%	-0.01%	0.85%	-0.13%	-0.17%	0.02%	0.13%	0.27%
Book Value per Share	7.50	7.78	8.07	7.90	14.61	12.72	10.48	11.16	12.79	16.03
Total Shareholders' Equity	908.52M	905.9M	932.6M	916.24M	770.97M	1.06B	1.11B	1.12B	1.29B	1.68B
Common Stock	131K	132K	134K	135K	134K	135K	134K	127K	128K	129K
Retained Earnings	434.62M	371.69M	359.74M	320.35M	279.8M	553.24M	593.25M	581.01M	751.86M	770.15M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-448.72M	-512.75M	-630.66M	-764.58M	0	-2.03M	12.28M	88.6M	42.91M	0
Minority Interest	49.26M	90.18M	109.24M	113.2M	1.13B	590.66M	254.95M	268.69M	285.71M	315.74M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	208.41M	346.6M	238.13M	494.19M	445.18M	1.03B	401.23M	284.82M	582.06M	517.86M
Operating CF Margin %	0.06%	0.08%	0.05%	0.1%	0.08%	0.19%	0.06%	0.04%	0.09%	0.1%
Operating CF Growth %	0.22%	0.66%	-0.31%	1.08%	-0.1%	1.31%	-0.61%	-0.29%	1.04%	-0.11%
Net Income	136M	125.27M	220.65M	176.94M	201.03M	344.61M	499.95M	198.03M	299.73M	296.7M
Depreciation & Amortization	104.98M	145.31M	160.01M	201.66M	212.58M	205.66M	202.65M	205.82M	208.74M	203.89M
Stock-Based Compensation	14.98M	17.41M	19.28M	23.33M	26.45M	27.25M	30.94M	37.76M	43.81M	100.67M
Deferred Taxes	-2.06M	-12.59M	-72.32M	7.22M	-7.43M	-14.71M	5.05M	7.52M	-16.12M	-32.43M
Other Non-Cash Items	35.33M	52.98M	85.75M	656K	25.65M	-13.82M	-7.38M	-4.76M	-13.6M	4.17M
Working Capital Changes	-80.82M	18.22M	-175.24M	84.4M	-13.09M	479.1M	-329.98M	-159.54M	59.5M	-55.14M
Change in Receivables	-92.57M	-39.32M	-197.19M	54.58M	-57.99M	-116.6M	23.1M	-52.18M	1.16M	-95.84M
Change in Inventory	4.7M	17.45M	1.6M	0	0	167.65M	-82.77M	0	0	0
Change in Payables	2.35M	30.8M	21.24M	26.12M	5.74M	27.32M	53.39M	-48.04M	-6.41M	-16.79M
Cash from Investing+	-1.21B	-554.32M	-192.97M	-697.14M	-316.73M	-115.35M	-256.59M	-226.34M	-268.48M	-231.01M
Capital Expenditures	-182.64M	-161.63M	-233.24M	-167.28M	-157.13M	-146.44M	-180.54M	-190.37M	-229.2M	-222.18M
CapEx % of Revenue	0.05%	0.04%	0.05%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	1.77M	80.46M	80.35M	6.76M	192K	83.32M	26.82M	8.34M	163K	4.26M
Cash from Financing+	1.01B	292.31M	-21.65M	255.57M	32.25M	-671.54M	-647.38M	-34.89M	-327.48M	-311.17M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-13.13M	0	0	0	0	0	-50.6M	-64.59M	-63.9M	-64.62M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	206.83M	864K	1.38M	-308.51M	-2.68M	-607.39M	-713.01M	-39.45M	-46.86M	-226.38M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	25.77M	184.97M	4.89M	326.91M	288.06M	881.63M	220.69M	94.45M	352.86M	539.65M
FCF Margin %	0.01%	0.04%	0%	0.06%	0.05%	0.16%	0.04%	0.01%	0.05%	0.1%
FCF Growth %	-0.66%	6.18%	-0.97%	65.88%	-0.12%	2.06%	-0.75%	-0.57%	2.74%	0.53%
FCF per Share	0.20	1.45	0.04	2.51	2.21	6.79	1.69	0.76	2.87	4.33
FCF Conversion (FCF/Net Income)	1.59x	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x
Interest Paid	103.17M	142.64M	149.16M	193.41M	182.99M	155.24M	132.2M	183.45M	272.26M	256.23M
Taxes Paid	79.42M	70.76M	64.99M	48.15M	70.59M	108.89M	181.18M	32.29M	88.51M	133.19M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	14.78%	11.81%	17.39%	13.31%	10.12%	14.57%	26.67%	11.54%	16.43%	11.99%
Return on Invested Capital (ROIC)	7.13%	6.4%	7.36%	8.06%	6.93%	7.31%	9.21%	4.84%	6.66%	3.77%
Gross Margin	14.19%	14.49%	15.97%	14.57%	14.91%	14.85%	14.82%	11.58%	13.99%	12.22%
Net Margin	3.49%	2.69%	3.99%	2.71%	2.72%	4.68%	6.48%	2.51%	3.65%	4.13%
Debt / Equity	2.56x	2.75x	2.59x	3.20x	2.37x	2.72x	3.49x	3.71x	2.87x	1.35x
Interest Coverage	2.44x	1.76x	2.30x	2.10x	2.35x	3.71x	5.25x	2.38x	2.79x	2.09x
FCF Conversion	1.59x	3.00x	1.34x	3.59x	3.00x	3.97x	1.00x	1.79x	2.39x	2.42x
Revenue Growth	22.11%	14.52%	3.68%	14.35%	7.33%	1.43%	12.16%	2.08%	5.22%	-22.16%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Health Care, Patient Service, Non-Medicare	-	-	-	-	3.63B	3.72B	4.36B	4.42B	4.69B	3.18B
Health Care, Patient Service, Non-Medicare Growth	-	-	-	-	-	2.65%	17.23%	1.33%	5.98%	-32.06%
Health Care, Patient Service, Medicare	-	-	-	-	1.41B	1.38B	1.42B	1.45B	1.49B	1.49B
Health Care, Patient Service, Medicare Growth	-	-	-	-	-	-2.06%	2.46%	2.08%	2.59%	0.39%
Service, Other	-	-	-	-	413.21M	424.23M	421.71M	462.98M	491.64M	511.57M
Service, Other Growth	-	-	-	-	-	2.67%	-0.59%	9.78%	6.19%	4.05%
Health Care, Patient Service	-	-	-	-	5.04B	5.11B	-	-	-	-
Health Care, Patient Service Growth	-	-	-	-	-	1.32%	-	-	-	-
Critical Illness Recovery Hospital	-	-	-	1.75B	-	-	-	-	-	-
Critical Illness Recovery Hospital Growth	-	-	-	-	-	-	-	-	-	-
Concentra	-	1B	1.03B	1.56B	-	-	-	-	-	-
Concentra Growth	-	-	3.34%	50.64%	-	-	-	-	-	-
Outpatient Rehabilitation	810.01M	995.37M	1.02B	1.06B	-	-	-	-	-	-
Outpatient Rehabilitation Growth	-	22.88%	2.56%	4.08%	-	-	-	-	-	-
Rehabilitation Hospital	-	-	-	707.51M	-	-	-	-	-	-
Rehabilitation Hospital Growth	-	-	-	-	-	-	-	-	-	-
Long Term Acute Care	-	-	1.76B	-	-	-	-	-	-	-
Long Term Acute Care Growth	-	-	-	-	-	-	-	-	-	-
Inpatient Rehabilitation	-	-	631.78M	-	-	-	-	-	-	-
Inpatient Rehabilitation Growth	-	-	-	-	-	-	-	-	-	-
Specialty Hospitals	2.35B	2.29B	-	-	-	-	-	-	-	-
Specialty Hospitals Growth	-	-2.44%	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Select Medical Holdings Corporation (SEM) has a price-to-earnings (P/E) ratio of 9.3x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Select Medical Holdings Corporation (SEM) reported $3.93B in revenue for fiscal year 2024. This represents a 40% increase from $2.80B in 2011.

Select Medical Holdings Corporation (SEM) saw revenue decline by 22.2% over the past year.

Yes, Select Medical Holdings Corporation (SEM) is profitable, generating $110.0M in net income for fiscal year 2024 (4.1% net margin).

Dividend & Returns

Yes, Select Medical Holdings Corporation (SEM) pays a dividend with a yield of 3.36%. This makes it attractive for income-focused investors.

Select Medical Holdings Corporation (SEM) has a return on equity (ROE) of 12.0%. This is reasonable for most industries.

Select Medical Holdings Corporation (SEM) generated $174.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...